Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Net
Ratios

Madrigal Pharmaceuticals (MDGL) Receivables - Net (2024 - 2025)

Madrigal Pharmaceuticals (MDGL) has disclosed Receivables - Net for 2 consecutive years, with $134.5 million as the latest value for Q4 2025.

  • Quarterly Receivables - Net rose 149.85% to $134.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $134.5 million through Dec 2025, up 149.85% year-over-year, with the annual reading at $134.5 million for FY2025, 149.85% up from the prior year.
  • Receivables - Net for Q4 2025 was $134.5 million at Madrigal Pharmaceuticals, up from $113.3 million in the prior quarter.
  • The five-year high for Receivables - Net was $134.5 million in Q4 2025, with the low at $6.9 million in Q2 2024.